Forlong Biotechnology raises $17.5m pre-Series B
Fudan Capital, Changshu Guofa Venture and Kunsheng Relay Fund participated in the oncology biotech's financing.
Forlong Biotechnology raised $17.5 million in pre-Series B financing on May 19. Participants included Fudan Capital, Changshu Guofa Venture and Kunsheng Relay Fund. The clinical-stage company develops cytokine therapies for cancer, including IL-15 and IL-18 programs.